https://www.businesswire.com/news/home/20260108654667/en/Xencor-Highlights-Corporate-Priorities-and-2026-Pipeline-Milestones
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, ...
corporate prioritiesxencorhighlightspipelinemilestones